Severe restless legs syndrome following bilateral subthalamic stimulation to treat a patient with Parkinson's disease [2];Síndrome de piernas inquietas grave tras estimulación subtalámica bilateral para tratar una paciente con enfermedad de Parkinson

Revista de Neurologia

Volumn 42, Issue 12, 2006, Pages 766-767

  Parra Martínez, Julio ^a   Brocalero Camacho, A ^a   Sancho, J ^a   Gallego Sanchez J M ^a   Ortiz Sanchez P ^a   Barcia Albacar, J A ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CARBEGOLINE; CARBIDOPA; CARBIDOPA PLUS LEVODOPA; CITALOPRAM; CLONAZEPAM; GABAPENTIN; LEVODOPA; PRAMIPEXOLE; ROPINIROLE; TRAMADOL; UNCLASSIFIED DRUG;

ADULT; BRAIN DEPTH STIMULATION; CASE REPORT; DEPRESSION; DISEASE SEVERITY; FEMALE; HUMAN; LETTER; PARKINSON DISEASE; RESTLESS LEGS SYNDROME; SUBTHALAMIC NUCLEUS; ELECTROSTIMULATION THERAPY; MIDDLE AGED; PHYSIOLOGY;

ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; MIDDLE AGED; PARKINSON DISEASE; RESTLESS LEGS SYNDROME; SUBTHALAMIC NUCLEUS;

EID: 33750109792     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4212.2006007     Document Type: Letter

References (10)

1. Thorpy MJ. New paradigms in the treatment of restless legs syndrome. Neurology 2005; 64 (Suppl): S28-33.
2. Allen RP, Picchietti D, Hening WA, Trenkwalders AS, Montplaisi J, Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institutes of Health International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. Sleep Med 2003; 4: 101-19.
3. Turjanski N, Lees AJ, Brooks DJ. Striatal dopaminergic function in restless legs syndrome 18F-dopa 11C-raclopride PET studies. Neurology 1999; 52: 932-7.
4. Poewe W, Högl B. Akathisia, restless leg and periodic limb movements in sleep in Parkinson disease. Neurology 2004; 63 (Suppl): S12-6.
5. Ondo WG, Dat Vuong K, Jankovic J. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002; 59: 421-4.
6. Kedia S, Moro E, Tagliati M, Lang AE, Kumar R. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease. Neurology 2004; 63: 2410-2.
7. Brown LK, Dedrick DL, Dogget JW, Guido PS. Antidepressant medication use and restless legs syndrome in patients presenting with insomnia. Sleep Med 2005; 6: 443-50.
8. Flórez J. Fármacos analgésicos opiodes. In Flórez J, Armijo JA, Mediavilla A, eds. Farmacología humana. Barcelona: Masson; 2003. p. 461-78.
9. Walters AS. Review of receptor agonist and antagonist studies relevant to the opiate system in restless legs syndrome. Sleep Med 2002; 3: 301-4.
10. Von Spiczak S, Whone AL, Hammers A, Asselin MC, Turkeimer F, Tings T, et al. The role of opioids in restless syndrome: an (11C) diprenorphine PET study. Brain 2005; 128: 906-17.